Enter at least 4 characters

for: 'continuous' in the Therapeutic Groups


4 results showing for: 'continuous'

Continuous glucose monitor (interoperable)    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 23.
- Continuous glucose monit: Brand switch fee payable.
- Only on a prescription
- Special Authority SA2371 [PDF]
-- Retail pharmacy
  • 3 to 6 month supply. Sensor (9) and transmitter (Dexcom G6) - Maximum of 1 dev per prescription
    • Brand Fully subsidised brand. Dexcom G6
    • Pharmacode2679795
    • Subsidy $990.00
    • Measure / Qty per 1 OP

    Maximum of 5 dev will be funded per year.

  • 3 to 6 month supply. Sensor (Dexcom G7) - Maximum of 9 dev per prescription
    • Brand Fully subsidised brand. Dexcom G7
    • Pharmacode2679809
    • Subsidy $110.00
    • Measure / Qty per 1

    Maximum of 40 dev will be funded per year.

  • 3 to 6 month supply. Sensor (Freestyle Libre 3 Plus) - Maximum of 6 dev per prescription
    • Brand Fully subsidised brand. Freestyle Libre 3 Plus
    • Pharmacode2691655
    • Subsidy $99.46
    • Measure / Qty per 1

    Maximum of 28 dev will be funded per year.

Continuous glucose monitor (standalone)    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 23.
- Continuous glucose monit: Brand switch fee payable.
- Only on a prescription
- Special Authority SA2370 [PDF]
-- Retail pharmacy
  • 3 to 6 month supply. Sensor (Dexcom ONE+) - Maximum of 9 dev per prescription
    • Brand Fully subsidised brand. Dexcom ONE+
    • Pharmacode2679817
    • Subsidy $81.00
    • Measure / Qty per 1

    Maximum of 40 dev will be funded per year.

  • 3 to 6 month supply. Sensor (Freestyle Libre 2) - Maximum of 7 dev per prescription
    • Brand Fully subsidised brand. Freestyle Libre 2
    • Pharmacode2682249
    • Subsidy $92.83
    • Measure / Qty per 1

    Maximum of 29 dev will be funded per year.

  • 3 to 6 month supply. Brand switch fee
    • Brand Fully subsidised brand. BSF Eltroxin
    • Pharmacode2689251
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Pomolide
    • Pharmacode2689278
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Lenalidomide (Viatris)
    • Pharmacode2689286
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Alyacen
    • Pharmacode2692112
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Norethinderone - CDC
    • Pharmacode2692120
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (standalo
    • Pharmacode2692139
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (interope
    • Pharmacode2692147
    • Subsidy $4.50
    • Measure / Qty per 1
    (BSF Eltroxin Brand switch fee to be delisted 01 December 2024)
    (BSF Pomolide Brand switch fee to be delisted 01 December 2024)
    (BSF Lenalidomide (Viatris) Brand switch fee to be delisted 01 December 2024)
    (BSF Alyacen Brand switch fee to be delisted 01 January 2025)
    (BSF Norethinderone - CDC Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (standalo Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (interope Brand switch fee to be delisted 01 January 2025)

    May only be claimed once per patient.

  • 3 to 6 month supply. Brand switch fee
    • Brand Fully subsidised brand. BSF Eltroxin
    • Pharmacode2689251
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Pomolide
    • Pharmacode2689278
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Lenalidomide (Viatris)
    • Pharmacode2689286
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Alyacen
    • Pharmacode2692112
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Norethinderone - CDC
    • Pharmacode2692120
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (standalo
    • Pharmacode2692139
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (interope
    • Pharmacode2692147
    • Subsidy $4.50
    • Measure / Qty per 1
    (BSF Eltroxin Brand switch fee to be delisted 01 December 2024)
    (BSF Pomolide Brand switch fee to be delisted 01 December 2024)
    (BSF Lenalidomide (Viatris) Brand switch fee to be delisted 01 December 2024)
    (BSF Alyacen Brand switch fee to be delisted 01 January 2025)
    (BSF Norethinderone - CDC Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (standalo Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (interope Brand switch fee to be delisted 01 January 2025)

    May only be claimed once per patient.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply